Clinical Trial Update: A Roll-over Study to Provide Continued Treatment With Lyophilized Pegaspargase (S95014) in Pediatric Patients With Acute Lymphoblastic Leukemia (ALL) [Phase 2]

View source ↗

Summary

A Phase 2 rollover study provided continued treatment with lyophilized pegaspargase (S95014) in pediatric patients with acute lymphoblastic leukemia; results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Lyophilized pegaspargase (S95014) (pegaspargase (S95014))

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2023-12-29